Literature DB >> 4541143

The epidemiology of favism.

M A Belsey.   

Abstract

Favism is a potential obstacle to the use of the fava bean in the development of a locally produced, inexpensive weaning food for the Middle East and North Africa. The purposes of this study were to define the epidemiology of favism, to evaluate the advisability of using the fava bean in a weaning food, and to suggest ways of avoiding or eliminating the toxic factor in the bean. Field observations, locally acquired data, and a literature review suggested that the use of the fava bean in a weaning food would be hazardous, but that the hazard might be overcome by using certain strains of the bean or, more particularly, by using old dried beans. The disease is usually directly related in time to the harvesting and availability of fresh beans, but it is also associated with fresh dried beans. On the basis of the age distribution of the disease, patterns of bean consumption, and local food taboos it appears that the toxic factor is concentrated in the skin of the bean, that it is heat-stable, that in dried beans it decreases with age, and that it crosses into the breast milk of lactating mothers. It also appears that disease expression may be a result of the interaction of several host factors, such as nutritional status and the consumption of other foods. These observations are consistent with the results of laboratory studies, which incriminate vicine, divicine, and DOPA in the etiology of favism.

Entities:  

Mesh:

Year:  1973        PMID: 4541143      PMCID: PMC2481045     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  34 in total

1.  [FAVISM IN GERMANY].

Authors:  G GEHRMANN; A STURM; D AMELUNG
Journal:  Dtsch Med Wochenschr       Date:  1963-09-27       Impact factor: 0.628

2.  Studies on favism. 3. Studies on the physiological activites of vicine in vitro.

Authors:  J Y LIN; K H LING
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1962-06-28

3.  Favism in a nursing infant.

Authors:  B EMANUEL; A SCHOENFELD
Journal:  J Pediatr       Date:  1961-02       Impact factor: 4.406

4.  Formation of the sex chromatin by a single X-chromosome in liver cells of Rattus norvegicus.

Authors:  S OHNO; W D KAPLAN; R KINOSITA
Journal:  Exp Cell Res       Date:  1959-10       Impact factor: 3.905

5.  A deficiency of glucose-6-phosphate dehydrogenase activity in erythrocytes from patients with favism.

Authors:  W H ZINKHAM; R E LENHARD; B CHILDS
Journal:  Bull Johns Hopkins Hosp       Date:  1958-04

6.  The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character.

Authors:  R J DERN; E BEUTLER; A S ALVING
Journal:  J Lab Clin Med       Date:  1954-08

7.  Relationship between reduced glutathione content and spontaneous haemolysis in shed blood.

Authors:  G FEGLER
Journal:  Nature       Date:  1952-10-11       Impact factor: 49.962

8.  [Research on favism. I].

Authors:  G RUSSO; V BALSAMO
Journal:  Pediatria (Napoli)       Date:  1962 May-Jun

9.  The frequency of glucose-6-phosphate dehydrogenase deficiency in the newborns and adults in Kuwait.

Authors:  Y Shaker; A Onsi; R Aziz
Journal:  Am J Hum Genet       Date:  1966-11       Impact factor: 11.025

10.  Glutathione metabolism. II. The oxidation and reduction of glutathione in intact erythrocytes.

Authors:  S J KLEBANOFF
Journal:  Biochem J       Date:  1957-03       Impact factor: 3.857

View more
  11 in total

1.  Glucose-6-phosphate dehydrogenase deficiency and sulfadimidin acetylation phenotypes in Egyptian oases.

Authors:  L Hussein; G Yamamah; A Saleh
Journal:  Biochem Genet       Date:  1992-04       Impact factor: 1.890

Review 2.  Significance for humans of biologically active factors in soybeans and other food legumes.

Authors:  I Liener
Journal:  J Am Oil Chem Soc       Date:  1979-03       Impact factor: 1.849

Review 3.  Anti-nutritional and toxic factors in food legumes: a review.

Authors:  Y P Gupta
Journal:  Plant Foods Hum Nutr       Date:  1987       Impact factor: 3.921

4.  Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors.

Authors:  Thomas De Raedt; Zandra Walton; Jessica L Yecies; Danan Li; Yimei Chen; Clare F Malone; Ophélia Maertens; Seung Min Jeong; Roderick T Bronson; Valerie Lebleu; Raghu Kalluri; Emmanuel Normant; Marcia C Haigis; Brendan D Manning; Kwok-Kin Wong; Kay F Macleod; Karen Cichowski
Journal:  Cancer Cell       Date:  2011-09-13       Impact factor: 31.743

Review 5.  Faba Bean: An Untapped Source of Quality Plant Proteins and Bioactives.

Authors:  Delphine Martineau-Côté; Allaoua Achouri; Salwa Karboune; Lamia L'Hocine
Journal:  Nutrients       Date:  2022-04-07       Impact factor: 6.706

6.  Favism: looking for an autosomal gene associated with glucose-6-phosphate dehydrogenase deficiency.

Authors:  C Mareni; L Repetto; G Forteleoni; T Meloni; G F Gaetani
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

7.  Glucose-6-phosphate dehydrogenase variants associated with favism in Thai children.

Authors:  Vichai Laosombat; Benjamas Sattayasevana; Teerachit Chotsampancharoen; Malai Wongchanchailert
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

8.  Gas Chromatography/Mass Spectrometry-Based Metabolomic Profiling Reveals Alterations in Mouse Plasma and Liver in Response to Fava Beans.

Authors:  Man Xiao; Guankui Du; Guobing Zhong; Dongjing Yan; Huazong Zeng; Wangwei Cai
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

9.  Effect of the antibiotic neomycin on the toxicity of the glycoside vicine in rats.

Authors:  Mahmoud S Arbid; Khaled M M Koriem; Gihan F Asaad; Hoda A Megahed
Journal:  J Toxicol       Date:  2013-06-12

10.  Medical expenses of patients with Favism admitted to 17th Shahrivar Hospital compared to G6PD enzyme screening cost, in north of Iran.

Authors:  B Darbandi; M Noghbaei; F Mehrabian; M Jafroodi
Journal:  Iran J Ped Hematol Oncol       Date:  2014-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.